# Metlife Inc: filings

MET · NYSE · CIK 1099219 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/met.md) · [Financials](/companies/met/financials.md) · [Filings](/companies/met/filings.md) · [Insiders](/companies/met/insiders.md)

## Reports and events: 649 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1749, 8-K 469, 144 88, SC 13D/A 72, 10-Q 53, 3 46, 424B2 41, 13F-HR 34, 11-K 32, FWP 29, UPLOAD 29, CORRESP 27, SC 13G/A 27, 13F-HR/A 26, 424B5 20, DEF 14A 19, 10-K 18, DEFA14A 15, 13F-NT 14, ARS 12, 4/A 8, S-8 8, 8-K/A 7, S-8 POS 7, SCHEDULE 13D/A 7, S-3ASR 6, SC 13G 6, 3/A 5, D/A 5, 15-15D 4, 25-NSE 4, 40-APP/A 4, PRE 14A 4, SC 13E3/A 4, SC TO-T/A 4, 8-A12B 3, 8-A12G 3, IRANNOTICE 3, N-PX 3, SCHEDULE 13G/A 3, SC TO-C 3, 10-K/A 2, 144/A 2, 424B7 2, CERT 2, SC TO-I/A 2, 10-Q/A 1, 424B3 1, 5 1, 8-A12B/A 1, APP NTC 1, APP ORDR 1, CERTNYS 1, NO ACT 1, PX14A6G 1, REGDEX 1, REGDEX/A 1, SC 13D 1, SC 13E3 1, SCHEDULE 13G 1, SC TO-I 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 20:06 ET | [8-K](/filings/0001099219-26-000055.md) | 7.01 Regulation FD disclosure | 0001099219-26-000055 |
| 2026-08-17 | 20:30 ET | [8-K](/filings/0001099219-26-000052.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000052 |
| 2026-08-06 | 20:56 ET | [SCHEDULE 13D/A](/filings/0001193125-26-338366.md) | Ownership report, active investor, amended | 0001193125-26-338366 |
| 2026-08-06 | 20:32 ET | [10-Q](/filings/0001099219-26-000050.md) | Quarterly report, period 2026-06-30 | 0001099219-26-000050 |
| 2026-08-05 | 20:31 ET | [8-K](/filings/0001099219-26-000048.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000048 |
| 2026-06-29 | 10:27 ET | [8-K](/filings/0001099219-26-000045.md) | 7.01 Regulation FD disclosure | 0001099219-26-000045 |
| 2026-06-22 | 20:21 ET | [8-K](/filings/0001099219-26-000041.md) | 5.07 Shareholder vote results | 0001099219-26-000041 |
| 2026-05-15 | 20:18 ET | [8-K](/filings/0001099219-26-000037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000037 |
| 2026-05-07 | 21:42 ET | [SCHEDULE 13D/A](/filings/0001193125-26-212514.md) | Ownership report, active investor, amended | 0001193125-26-212514 |
| 2026-05-07 | 21:09 ET | [10-Q](/filings/0001099219-26-000035.md) | Quarterly report, period 2026-03-31 | 0001099219-26-000035 |
| 2026-05-06 | 20:31 ET | [8-K](/filings/0001099219-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000032 |
| 2026-04-29 | 20:29 ET | [DEF 14A](/filings/0001099219-26-000026.md) | Proxy statement, period 2026-06-16 | 0001099219-26-000026 |
| 2026-04-07 | 10:05 ET | [8-K](/filings/0001099219-26-000019.md) | 7.01 Regulation FD disclosure | 0001099219-26-000019 |
| 2026-03-05 | 21:24 ET | [8-K](/filings/0001099219-26-000015.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000015 |
| 2026-02-26 | 21:12 ET | [8-K](/filings/0001193125-26-076647.md) | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-076647 |
| 2026-02-24 | 21:21 ET | [8-K](/filings/0001193125-26-067070.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-067070 |
| 2026-02-19 | 22:34 ET | [SCHEDULE 13D/A](/filings/0001193125-26-059738.md) | Ownership report, active investor, amended | 0001193125-26-059738 |
| 2026-02-19 | 21:34 ET | [10-K](/filings/0001099219-26-000013.md) | Annual report, period 2025-12-31 | 0001099219-26-000013 |
| 2026-02-17 | 21:33 ET | [8-K](/filings/0001099219-26-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000010 |
| 2026-02-04 | 22:07 ET | [8-K](/filings/0001099219-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-26-000008 |
| 2026-01-09 | 11:53 ET | [8-K](/filings/0001099219-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001099219-26-000005 |
| 2025-12-30 | 11:03 ET | [8-K](/filings/0001099219-25-000241.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000241 |
| 2025-12-22 | 11:18 ET | [8-K](/filings/0001099219-25-000239.md) | 7.01 Regulation FD disclosure | 0001099219-25-000239 |
| 2025-12-01 | 21:57 ET | [8-K](/filings/0001099219-25-000234.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001099219-25-000234 |
| 2025-11-17 | 21:29 ET | [8-K](/filings/0001099219-25-000232.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000232 |
| 2025-11-06 | 23:11 ET | [SCHEDULE 13D/A](/filings/0001193125-25-270254.md) | Ownership report, active investor, amended | 0001193125-25-270254 |
| 2025-11-07 | 23:00 ET | [10-Q](/filings/0001099219-25-000230.md) | Quarterly report, period 2025-09-30 | 0001099219-25-000230 |
| 2025-11-05 | 21:32 ET | [8-K](/filings/0001099219-25-000227.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000227 |
| 2025-10-14 | 20:14 ET | [8-K](/filings/0001099219-25-000224.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001099219-25-000224 |
| 2025-09-22 | 12:01 ET | [8-K](/filings/0001099219-25-000222.md) | 7.01 Regulation FD disclosure | 0001099219-25-000222 |
| 2025-09-15 | 20:33 ET | [8-K](/filings/0001099219-25-000219.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000219 |
| 2025-09-02 | 20:26 ET | [8-K](/filings/0001193125-25-194038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-194038 |
| 2025-08-15 | 20:21 ET | [8-K](/filings/0001099219-25-000201.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000201 |
| 2025-08-07 | 20:34 ET | [SCHEDULE 13D/A](/filings/0000950170-25-105122.md) | Ownership report, active investor, amended | 0000950170-25-105122 |
| 2025-08-07 | 20:21 ET | [10-Q](/filings/0001099219-25-000193.md) | Quarterly report, period 2025-06-30 | 0001099219-25-000193 |
| 2025-08-06 | 20:50 ET | [8-K](/filings/0001099219-25-000191.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000191 |
| 2025-07-30 | 20:16 ET | [8-K](/filings/0001193125-25-169311.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-169311 |
| 2025-07-01 | 20:26 ET | [8-K](/filings/0001193125-25-154039.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-154039 |
| 2025-06-23 | 20:08 ET | [8-K](/filings/0001099219-25-000186.md) | 7.01 Regulation FD disclosure | 0001099219-25-000186 |
| 2025-06-20 | 20:19 ET | [8-K](/filings/0001099219-25-000174.md) | 5.07 Shareholder vote results | 0001099219-25-000174 |
| 2025-06-17 | 20:21 ET | [8-K](/filings/0001193125-25-142086.md) | 2.03 New direct financial obligation | 0001193125-25-142086 |
| 2025-05-15 | 20:20 ET | [8-K](/filings/0001099219-25-000139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000139 |
| 2025-05-01 | 21:45 ET | [SCHEDULE 13D/A](/filings/0000950170-25-062068.md) | Ownership report, active investor, amended | 0000950170-25-062068 |
| 2025-05-01 | 21:21 ET | [10-Q](/filings/0001099219-25-000135.md) | Quarterly report, period 2025-03-31 | 0001099219-25-000135 |
| 2025-04-30 | 20:44 ET | [8-K](/filings/0001193125-25-107504.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-107504 |
| 2025-04-30 | 20:33 ET | [8-K](/filings/0001099219-25-000133.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000133 |
| 2025-04-29 | 20:17 ET | [DEF 14A](/filings/0001099219-25-000126.md) | Proxy statement, period 2025-06-17 | 0001099219-25-000126 |
| 2025-03-28 | 20:44 ET | [8-K](/filings/0001193125-25-067184.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-067184 |
| 2025-03-13 | 20:31 ET | [8-K](/filings/0001193125-25-053957.md) | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-053957 |
| 2025-03-05 | 21:20 ET | [8-K](/filings/0001099219-25-000077.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099219-25-000077 |

Page 1 of 13. [Older](/companies/met/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.